Department of Pediatrics, University of Colorado Denver School of Medicine and The Children's Hospital, Aurora, CO 80045, USA.
J Perinatol. 2010 Feb;30(2):127-34. doi: 10.1038/jp.2009.139. Epub 2009 Oct 1.
The aim of this study was to describe the school-age outcome of a cohort of children treated with intensive care support for persistent pulmonary hypertension of the newborn (PPHN).
From 187 term newborns treated for PPHN as neonates, 109 were seen at school age (73% of 150 survivors and 58.2% of the original cohort). Of these 109 term newborns, 77 were treated with inhaled nitric oxide (iNO); of which 12 received extracorporeal membrane oxygenation (ECMO). The remaining 32 received conventional management with no exposure to iNO. Patients were seen at school age (mean 7.1 years). A medical history and physical exam were completed, growth was measured, and chest X-ray and echocardiogram were performed. Psychometric assessments included the Wechsler Scales (Preschool or Child), Vineland Adaptive Behavior Scales, Kaufman Test of Educational Achievement, Children's Category Test, Wisconsin Card Sorting Test and Achenbach Child Behavior Checklist.
Medical, neurodevelopmental and social/emotional/behavioral outcome did not differ between children treated with iNO, with or without ECMO, and those managed with no exposure to iNO. Overall, 24% had respiratory problems, 60% had abnormal chest X-rays and 6.4% had some sensorineural hearing loss. The cohort performed at the average level for full scale IQ, adaptive function, academic achievement, higher-order cognition and executive functioning, and social/behavioral/emotional functioning. Overall, 9.2% of the cohort had a full scale IQ less than 70 and 7.4% had an IQ from 70 to 84.
The outcome for this cohort of children treated as newborns for PPHN, which included a large group of infants exposed to iNO, was comparable to previous reports of children treated with ECMO or conventionally.
本研究旨在描述接受新生儿持续肺动脉高压(PPHN)强化治疗的患儿队列的学龄期结局。
从 187 例接受 PPHN 治疗的足月新生儿中,有 109 例在学龄期接受了随访(存活者的 73%和原始队列的 58.2%)。在这 109 例足月新生儿中,77 例接受了吸入一氧化氮(iNO)治疗;其中 12 例接受了体外膜氧合(ECMO)治疗。其余 32 例接受了常规治疗,未接触 iNO。患者在学龄期(平均 7.1 岁)接受随访。完成了病史和体格检查,测量了生长情况,并进行了胸部 X 线和超声心动图检查。心理评估包括韦氏智力量表(学前或儿童)、文兰适应行为量表、考夫曼教育成就测验、儿童类别测验、威斯康星卡片分类测验和 Achenbach 儿童行为检查表。
接受 iNO 治疗、联合或不联合 ECMO 治疗以及未接受 iNO 治疗的患儿的医疗、神经发育和社会/情感/行为结局无差异。总体而言,24%的患儿有呼吸系统问题,60%的患儿胸部 X 线异常,6.4%的患儿有一定程度的感觉神经性听力损失。该队列在全量表智商、适应功能、学业成绩、高阶认知和执行功能以及社会/行为/情感功能方面的表现处于平均水平。总体而言,9.2%的患儿全量表智商低于 70,7.4%的患儿智商在 70 到 84 之间。
本队列中接受新生儿 PPHN 强化治疗的患儿的结局,包括接触 iNO 的大量婴儿,与接受 ECMO 或常规治疗的患儿的既往报道结果相当。